ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 233 filers reported holding ROYALTY PHARMA PLC in Q3 2021. The put-call ratio across all filers is 0.36 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,594,123 | +5.1% | 132,429 | +19.1% | 0.03% | +14.8% |
| Q2 2023 | $3,418,565 | -14.4% | 111,209 | +0.3% | 0.03% | -20.6% |
| Q1 2023 | $3,994,070 | -20.2% | 110,854 | -12.4% | 0.03% | -22.7% |
| Q4 2022 | $5,003,825 | +30.2% | 126,615 | +32.4% | 0.04% | +25.7% |
| Q3 2022 | $3,843,000 | -24.5% | 95,638 | -21.0% | 0.04% | -12.5% |
| Q2 2022 | $5,090,000 | -0.2% | 121,058 | -7.5% | 0.04% | +29.0% |
| Q1 2022 | $5,101,000 | -11.5% | 130,932 | -9.5% | 0.03% | +3.3% |
| Q4 2021 | $5,765,000 | +33.9% | 144,665 | +21.4% | 0.03% | +15.4% |
| Q3 2021 | $4,307,000 | +1057.8% | 119,189 | +1214.7% | 0.03% | +1200.0% |
| Q2 2021 | $372,000 | – | 9,066 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SIGULER GUFF ADVISERS, LLC | 6,761,970 | $338,436,000 | 92.73% |
| Vantage Consulting Group Inc | 21,477,282 | $1,074,938,000 | 87.53% |
| Memorial Sloan Kettering Cancer Center | 3,565,887 | $178,473,000 | 75.56% |
| HARVARD MANAGEMENT CO INC | 14,690,780 | $735,274,000 | 39.88% |
| ROBERT WOOD JOHNSON FOUNDATION | 3,958,498 | $1,981,228,000 | 21.69% |
| Brown University | 381,759 | $19,107,000 | 13.82% |
| Overbrook Management Corp | 778,511 | $38,964,000 | 9.50% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 38,714,280 | $1,937,650,000 | 4.22% |
| Lagoda Investment Management, L.P. | 96,885 | $4,849,000 | 2.61% |
| HealthCor Management, L.P. | 1,339,530 | $67,043,000 | 2.58% |